JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis

J Cancer Res Clin Oncol. 2014 Jun;140(6):969-78. doi: 10.1007/s00432-014-1646-y. Epub 2014 Mar 27.

Abstract

Purpose: To elucidate the clinicopathological significance and the role of Jun Activation Domain-Binding Protein 1 (JAB1), Ser10-phosphorylated p27 (p27S10), and total p27 in human hepatocellular carcinoma (HCC) prognosis.

Methods: We evaluated the expression of JAB1 and p27S10 in tissues by immunohistochemical and immunoblot analyses. p27 Ser10 phosphorylation and Ser10 phosphorylation-dependent p27-JAB1 interaction were demonstrated in proliferating Huh7 cells following transfection of pEGFP-p27WT/p27S10A/p27S10D plasmids and pcDNA3.1-p27WT/p27S10A/p27S10D-Myc plasmids. Univariate and multivariate analysis were used to determine their role in HCC prognosis.

Results: JAB1 and p27S10 are overexpressed in HCC samples compared with paired normal tissues. There was a strong correlation between JAB1 and p27S10 expression (P < 0.001), and expression of both inversely correlated with total p27 levels (P < 0.001). High JAB1 and p27S10 expression correlated with histological grade, vascular invasion, and serum α-fetoprotein (AFP) level (all P < 0.01). Total p27 expression also correlated with histological tumor grade (P = 0.048) and AFP level (P = 0.015). The p27S10(high)/JAB1(high)/p27(1ow) profile was the most reliable indication of poor prognostic. Ser10 phosphorylation increased and total p27 levels decreased in a time-dependent manner in serum-starved Huh7 cells following addition of serum. Immunoprecipitation analysis revealed that p27 Ser-to-Asp substitution at position 10 (S10D) markedly enhanced the interaction between JAB1 and p27, but replacement of S10A reduced binding.

Conclusions: This study revealed that combined JAB1, p27S10, and total p27 expression may serve as a prognostic marker for HCC.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blotting, Western
  • COP9 Signalosome Complex
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / mortality
  • Case-Control Studies
  • Cyclin-Dependent Kinase Inhibitor p27 / genetics
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism*
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoenzyme Techniques
  • Immunoprecipitation
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / mortality
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Mutagenesis, Site-Directed
  • Mutation / genetics
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Peptide Hydrolases / metabolism*
  • Phosphorylation
  • Prognosis
  • Survival Rate
  • Tumor Cells, Cultured
  • alpha-Fetoproteins / metabolism

Substances

  • CDKN1B protein, human
  • Intracellular Signaling Peptides and Proteins
  • alpha-Fetoproteins
  • Cyclin-Dependent Kinase Inhibitor p27
  • Peptide Hydrolases
  • COPS5 protein, human
  • COP9 Signalosome Complex